Think You Know the Latest ASH Leukemia & Lymphoma Research?
Do you remember the leukemia and lymphoma research presented at ASH? Test your knowledge now and see how you rank!
Read More
Dissemination (Meeting Coverage)
Psoriasis Management Alignment Needed Between Patients & Physicians
A study on the nuanced landscape of psoriasis sheds light on the intricate interplay between patient experiences and physician perspectives.
Read More
Don’t Miss the ACTRIMS Kenneth P. Johnson Memorial Lecture!
The ACTRIMS Forum 2024 Kenneth P. Johnson Memorial Lecture, “Pioneering B-Cell Therapies,” will be given by Anne H. Cross, MD.
Read More
ACTRIMS Young Investigators Present “Emerging Concepts in MS”
ACTRIMS Forum 2024 launches with Session 1: “Emerging Concepts in MS,” composed of presentations by Young Investigators selected from submitted abstracts.
Read More
Spend Time at The Square During ACTRIMS Forum 2024
Take a little time during ACTRIMS Forum 2024 to explore The Square, a dynamic neighborhood offering more than 50 shops and restaurants as well as local events.
Read More
Patients With Inactive Inflammatory Bowel Disease May Experience Flares After Colonoscopy
After a colonoscopy, patients with inactive IBD were more likely to present to the ED, be hospitalized, and be prescribed steroids within 30 days.
Read More
Real-World Impacts of ‘Special Area Involvement’ in Patients With Psoriasis
Patients with psoriasis in special areas report greater HRQOL impairment and symptom severity compared with those without special area involvement.
Read More
Physicians Should Screen Patients With Psoriasis for Cardiovascular Risk Factors
Patients with psoriasis are known to be at a higher risk of various cardiovascular risk factors.
Read More
Exploring MIs and Baseline Data Reported in IBD Observational Studies
The following is a summary of “Baseline Data and Measurement Instruments Reported in Observational...
Read More
Unveiling the Culinary Connection: How Diet Shapes the Landscape of IBD
Several studies were presented at the 2024 Crohn’s & Colitis Congress, covering the impacts on IBD of malnutrition, dietary supplements, and various diets.
Read More
IBD Increases Risk of Common Neurological Disorders in Adults
A recent study and meta-analysis revealed that inflammatory bowel disease (IBD) is associated with...
Read More
Preoperative Exclusive Enteral Nutrition Lowers Complication Risks in Crohn’s Disease Surgery
A study found that preoperative exclusive enteral nutrition (EEN) in patients with Crohn’s...
Read More
AI-Enhanced ‘Vascular Healing’ Analysis in Ulcerative Colitis Predicts Relapse
Investigators concluded that AI-powered “vascular healing” analysis in UC pinpointed patients...
Read More
Study Identifies “Significant Lack of Information” on HRQOL Measures in Psoriasis
Patient-reported outcomes on HRQOL in psoriasis are limited and require additional validation to properly assess individuals with the condition.
Read More
Patients With Acute Myeloid Leukemia & TP53 Mutation Have Lower Overall Survival, Complete Remission
Research from ASH 2023 showed standard treatment options lack efficacy for patients who are positive for the TP53 mutation with AML.
Read More
Advanced Therapy in IBD Shows Positive Impact on Extraintestinal Manifestations
A retrospective study on advanced therapy for Inflammatory Bowel Disease (IBD) found minimal new...
Read More
Extended RZV Use Linked to Lower Herpes Zoster Risk in Older Patients With IBD
A recent study found that long-term use of recombinant zoster vaccine (RZV) was associated with a...
Read More
Psoriasis Tied to Atherosclerosis
At Maui Derm Hawaii, Joel Gelfand, MD, MSCE, presented as part of “Challenging Cases in Psoriasis.” He published 2 related papers recently, which we summarize.
Read More
Meaningful Disease Burden Measurements in Patients With Psoriasis
Bruce Strober, MD, PhD, published a paper recently in JAMA Dermatol focusing on disease burden measurements of meaning to patients with psoriasis.
Read More
IL-23 p19 Inhibitors Safe for Moderate-to-Severe Plaque Psoriasis
At Maui Derm Hawaii, Andrew Blauvelt, MD, MBA, presented as part of “Psoriasis Update: 2024.” Here, we summarize a paper he published in this area of study.
Read More